Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure

dc.contributor.author

Rabik, Cara A

dc.contributor.author

Atkinson, Meredith A

dc.contributor.author

Sule, Sangeeta

dc.contributor.author

Strouse, John J

dc.date.accessioned

2017-10-02T02:48:50Z

dc.date.available

2017-10-02T02:48:50Z

dc.date.issued

2017-09-01

dc.description.abstract

Factor (F)XIII deficiency is a rare inherited bleeding disorder, but can also be acquired due to the development of inhibitors. CASE REPORT: A 17-year-old female with systemic lupus erythematosus and end-stage kidney disease secondary to Class IV lupus nephritis developed spontaneous subcutaneous and muscular hematomas and delayed major bleeding after invasive procedures. She had abnormal kaolin thromboelastography (kTEG; decreased maximal amplitude, representative of clot strength) initially attributed to thrombocytopenia and uremic platelet dysfunction, but her FXIII activity was undetectable, and a high-titer antibody against FXIII was identified. She had improvement in clinical bleeding and in kaolin thromboelastogram result and transient improvement in FXIII activity after each dose of plasma-derived FXIII concentrate (Corifact) or cryoprecipitate. Her inhibitor titers gradually improved with multiple immunosuppressive therapies and plasma exchange. While her FXIII activity level remained mildly decreased, she has not had additional significant bleeding. CONCLUSION: Treatment with either plasma-derived FXIII or cryoprecipitate is an effective treatment to normalize the kTEG variables and clinical bleeding diatheses associated with acquired FXIII inhibitors. Higher doses may be needed in patients with high-titer inhibitor.

dc.identifier.eissn

1537-2995

dc.identifier.issn

0041-1132

dc.identifier.uri

https://hdl.handle.net/10161/15607

dc.publisher

Wiley

dc.relation.ispartof

Transfusion

dc.relation.isversionof

10.1111/trf.14185

dc.title

Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure

dc.type

Journal article

duke.contributor.orcid

Strouse, John J|0000-0003-0341-1457

pubs.begin-page

2159

pubs.end-page

2163

pubs.issue

9

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Hematology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

57

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
F13 Final accepted.docx
Size:
163.78 KB
Format:
Unknown data format
Description:
Accepted version